132 related articles for article (PubMed ID: 18503633)
1. Protective effects of triflusal on secondary thrombus growth and vascular cyclooxygenase-2.
Duran X; Sánchez S; Vilahur G; Badimon L
J Thromb Haemost; 2008 Aug; 6(8):1385-92. PubMed ID: 18503633
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
[TBL] [Abstract][Full Text] [Related]
3. Effects of triflusal and its main metabolite HTB on platelet interaction with subendothelium in healthy volunteers.
De La Cruz JP; Villalobos MA; García PJ; Smith-Agreda JM; Sánchez de la Cuesta F
Eur J Clin Pharmacol; 1995; 47(6):497-502. PubMed ID: 7768251
[TBL] [Abstract][Full Text] [Related]
4. 4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation.
Bayón Y; Alonso A; Sánchez Crespo M
Br J Pharmacol; 1999 Mar; 126(6):1359-66. PubMed ID: 10217529
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia-reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids.
González-Correa JA; Arrebola MM; Ureña IM; Ruiz-Villafranca D; Muñoz-Marín J; Guerrero A; Sánchez de la Cuesta F; De La Cruz JP
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):81-8. PubMed ID: 15602657
[TBL] [Abstract][Full Text] [Related]
6. Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis.
Hong TT; Huang J; Barrett TD; Lucchesi BR
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H145-55. PubMed ID: 17921331
[TBL] [Abstract][Full Text] [Related]
7. Thrombosis is reduced by inhibition of COX-1, but unaffected by inhibition of COX-2, in an acute model of platelet activation in the mouse.
Armstrong PC; Kirkby NS; Zain ZN; Emerson M; Mitchell JA; Warner TD
PLoS One; 2011; 6(5):e20062. PubMed ID: 21629780
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
Schrör K
Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial.
Kalantzi KI; Ntalas IV; Chantzichristos VG; Tsoumani ME; Adamopoulos D; Asimakopoulos C; Bourdakis A; Darmanis P; Dimitriadou A; Gkiokas S; Ipeirotis K; Kitikidou K; Klonaris I; Kostaki A; Logothetis D; Mainas K; Mais T; Maragiannis A; Martiadou K; Mavronasos K; Michelongonas I; Mitropoulos D; Papadimitriou G; Papadopoulos A; Papaioakeim M; Sofillas K; Stabola S; Stefanakis E; Stergiou D; Thoma M; Zenetos A; Zisekas S; Goudevenos JA; Panagiotakos DB; Tselepis AD
Curr Vasc Pharmacol; 2019; 17(6):635-643. PubMed ID: 29866011
[TBL] [Abstract][Full Text] [Related]
10. Triflusal vs aspirin on the inhibition of human platelet and vascular cyclooxygenase.
de la Cruz JP; Mata JM; Sanchez de la Cuesta F
Gen Pharmacol; 1992 Mar; 23(2):297-300. PubMed ID: 1639242
[TBL] [Abstract][Full Text] [Related]
11. Comparison of in vitro effects of triflusal and acetysalicylic acid on nitric oxide synthesis by human neutrophils.
Sánchez de Miguel L; Casado S; Farré J; García-Durán M; Rico LA; Montón M; Romero J; Bellver T; Sierra MP; Guerra JI; Mata P; Esteban A; López-Farré A
Eur J Pharmacol; 1998 Feb; 343(1):57-65. PubMed ID: 9551715
[TBL] [Abstract][Full Text] [Related]
12. ASP6537, a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without "aspirin dilemma".
Sakata C; Kawasaki T; Kato Y; Abe M; Suzuki K; Ohmiya M; Funatsu T; Morita Y; Okada M
Thromb Res; 2013 Jul; 132(1):56-62. PubMed ID: 23522855
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase inhibitors: instrumental drugs to understand cardiovascular homeostasis and arterial thrombosis.
Bunimov N; Laneuville O
Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):268-77. PubMed ID: 19075637
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the inhibitory effects of acetylsalicylic acid and trifusal on enzymes related to thrombosis.
Garcia Rafanell J; Planas JM; Puig-Parellada P
Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):343-50. PubMed ID: 226020
[TBL] [Abstract][Full Text] [Related]
15. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
Hennan JK; Huang J; Barrett TD; Driscoll EM; Willens DE; Park AM; Crofford LJ; Lucchesi BR
Circulation; 2001 Aug; 104(7):820-5. PubMed ID: 11502709
[TBL] [Abstract][Full Text] [Related]
16. Platelet antiaggregatory effect of triflusal in human whole blood.
de la Cruz JP; Pavia J; Bellido I; González MC; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):273-7. PubMed ID: 3386335
[TBL] [Abstract][Full Text] [Related]
17. Effects and interaction studies of triflusal and other salicylic derivatives on cyclooxygenase in rats.
De Castellarnau C; Sancho MJ; Vila L; Albors M; Rutllant ML
Prostaglandins Leukot Essent Fatty Acids; 1988 Feb; 31(2):83-9. PubMed ID: 3128800
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
19. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
[TBL] [Abstract][Full Text] [Related]
20. Regulatory effects of HDL on smooth muscle cell prostacyclin release.
Viñals M; Martínez-González J; Badimon L
Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2405-11. PubMed ID: 10521370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
